XML 78 R67.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidating Financial Information (Details 3) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ 38,252 $ 79,798
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration 0 (24,402)
Acquisition of LCS, cash consideration 0 (307,403)
Proceeds from sale of property and equipment 43 123
Insurance proceeds - damaged property 548 901
Change in restricted cash and investments (65,853) (5,417)
Capital expenditures (46,014) (71,694)
Net cash used in investing activities (111,276) (407,892)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 641,000 518,000
Payments on long-term debt (627,506) (134,744)
Payments on non-recourse debt (3,044) (4,513)
Proceeds from non-recourse debt 159,068 49,731
Taxes paid related to net share settlements of equity awards (2,257) (1,784)
Proceeds from issuance of common stock in connection with ESPP 224 218
Debt issuance costs (19,497) (2,438)
Income tax (deficiency) benefit related to equity compensation (791) 651
Proceeds from the exercise of stock options 2,057 2,037
Cash dividends paid (97,247) (92,254)
Net cash provided by financing activities 52,007 334,904
Effect of Exchange Rate Changes on Cash and Cash Equivalents 244 (1,103)
Net (Decrease) Increase in Cash and Cash Equivalents (20,773) 5,707
Cash and Cash Equivalents, beginning of period 59,638 41,337
Cash and Cash Equivalents, end of period 38,865 47,044
The GEO Group, Inc.    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 84,523 39,103
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration  
Acquisition of LCS, cash consideration   (307,403)
Proceeds from sale of property and equipment 0 0
Insurance proceeds - damaged property 0 0
Change in restricted cash and investments (12) (97)
Capital expenditures (5,137) (36,367)
Net cash used in investing activities (5,149) (343,867)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 641,000 518,000
Payments on long-term debt (627,506) (134,744)
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt 0 0
Taxes paid related to net share settlements of equity awards (2,257) (1,784)
Proceeds from issuance of common stock in connection with ESPP 0 218
Debt issuance costs (16,980)
Income tax (deficiency) benefit related to equity compensation (791) 651
Proceeds from the exercise of stock options 2,057 2,037
Cash dividends paid (97,247) (92,254)
Net cash provided by financing activities (101,724) 292,124
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net (Decrease) Increase in Cash and Cash Equivalents (22,350) (12,640)
Cash and Cash Equivalents, beginning of period 37,077 18,492
Cash and Cash Equivalents, end of period 14,727 5,852
Combined Subsidiary Guarantors    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 40,602 62,486
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration   (24,402)
Acquisition of LCS, cash consideration  
Proceeds from sale of property and equipment 41 123
Insurance proceeds - damaged property 0 901
Change in restricted cash and investments (1,565) 2,396
Capital expenditures (39,078) (34,273)
Net cash used in investing activities (40,602) (55,255)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0
Payments on non-recourse debt 0 0
Proceeds from non-recourse debt 0 0
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 0
Debt issuance costs 0 0
Income tax (deficiency) benefit related to equity compensation 0 0
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0
Net cash provided by financing activities 0 0
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net (Decrease) Increase in Cash and Cash Equivalents 0 7,231
Cash and Cash Equivalents, beginning of period 0 782
Cash and Cash Equivalents, end of period 0 8,013
Combined Non-Guarantor Subsidiaries    
Cash Flow from Operating Activities:    
Net cash provided by operating activities (86,873) (21,791)
Cash Flow from Investing Activities:    
Acquisition of SoberLink, cash consideration  
Acquisition of LCS, cash consideration   0
Proceeds from sale of property and equipment 2 0
Insurance proceeds - damaged property 548 0
Change in restricted cash and investments (64,276) (7,716)
Capital expenditures (1,799) (1,054)
Net cash used in investing activities (65,525) (8,770)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt (3,044) (4,513)
Proceeds from non-recourse debt 159,068 49,731
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 224 0
Debt issuance costs (2,517) (2,438)
Income tax (deficiency) benefit related to equity compensation 0 0
Proceeds from the exercise of stock options 0 0
Cash dividends paid 0 0
Net cash provided by financing activities 153,731 42,780
Effect of Exchange Rate Changes on Cash and Cash Equivalents 244 (1,103)
Net (Decrease) Increase in Cash and Cash Equivalents 1,577 11,116
Cash and Cash Equivalents, beginning of period 22,561 22,063
Cash and Cash Equivalents, end of period $ 24,138 $ 33,179